We are the first company in China that launched the human insulin products. For more than 20 years, we have been engaged in the research and development (R&D), production, and marketing of insulin products that surpass international quality standards. Our products include a series of human insulin and insulin analogs.
Tonghua Dongbao has been persistent in continuous product innovation. The constant optimization of the product mix for diabetes treatment has enabled us to keep strengthening our market competitiveness and lead the domestic industry.
Tonghua Dongbao developed China's first recombinant human insulin, with a trade name of Gansulin, in 1998. As the first of its kind in China, Gansulin helped China overcome years of dependence on imports of the medicine. This achievement won the second prize of the National Science and Technology Progress Award and was listed in the "Top 10 Scientific Breakthroughs 1998". Let’s get a glimpse into Tonghua Dongbao from the following figures.
Year of founding
Production Output (2020)
Number of R&D staff
Categories of popular products